The most influential Megatrends set to shape the world through 2030, identified by Euromonitor International, help businesses better anticipate market developments and lead change for their industries.
Learn moreEuromonitor addresses your unique questions and challenges across all B2B and B2C industries and geographies through custom, tailor-made research projects, designed to your specific goals.
Learn moreOct 2020
US$990Added to Cart
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
Early in the COVID-19 outbreak, a recommendation by French doctors against the use of ibuprofen medication raised the alarm across the world in terms of its safety in treating COVID-19 symptoms. The World Health Organization followed up and briefly issued a recommendation for paracetamol, known in the US as acetaminophen, over ibuprofen, before also soon adding that it did not advice against the use of ibuprofen.
Johnson & Johnson saw a strong spike in demand for its Tylenol painkillers in mid-March and continued to see sustained demand throughout the spring. The conflicting reports about the safety of using ibuprofen to treat COVID-19 symptoms had a lasting impact, as Tylenol initially struggled to sustain enough supply for the increased demand in many retailers throughout the US and reported a temporary scarcity of Tylenol.
GlaxoSmithKline temporarily pulled Excedrin Extra Strength and Excedrin Migraine products off the shelves in January 2020 over inconsistencies in the transfer and weighing of ingredients. In turn, Excedrin products missed the tremendous growth opportunity that other analgesic products saw during the panic-buying period in mid-March.
Files are delivered directly into your account within a few minutes of purchase.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.
Delivery: Files are delivered directly into your account within a few minutes of purchase.
Overview
Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in USA with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Analgesics industry in USA, our research will save you time and money while empowering you to make informed, profitable decisions.
The Analgesics in USA market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.